9 research outputs found
Supplementary Figure 4 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Figure 4</p
Supplementary Table S1-S5 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Table S1-S5</p
Supplementary Figure 1 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Figure 1</p
Supplementary Figure 5 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Figure 5</p
Supplementary Figure 8 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Figure 8</p
Supplementary Figure 7 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Figure 7</p
Supplementary Figure 3 from Kinase inhibitor pulldown assay identifies a chemotherapy response signature in triple negative breast cancer based on purine-binding proteins
Supplementary Figure 3</p